3.125USD-0.16%Mkt Cap: 804.47M USDP/E: InfinityLast update: 2026-05-26
Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's …
Industry Peers
Drug Manufacturers - Specialty & Generic152.45BSEKP/E 166.3
58.11BTRYP/E 27.8
55.80BEURP/E 22.1
33.63BPLNP/E 21.9
24.50BUSDP/E 21.3
18.90BUSD—
15.76BUSDP/E 24.1
13.30BEURP/E 30.3
Indicators:|
Key Statistics
Company
Market Cap804.47M USD
Enterprise Value1.19B USD
Revenue (TTM)418.24M USD
Gross Profit273.91M USD
Net Income (TTM)-22.68M USD
Revenue/Share1.887 USD
Last Price3.125 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees294
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS29664W1053
Valuation
P/E (Trailing)Infinity
P/E (Forward)10.72
PEG—
EV/EBITDA15.72
EV/Revenue2.85
P/S1.93
P/B-2.54
EPS (TTM)0.00
EPS (Forward)0.29
52W Range
0.760069% of range4.180
52W High4.180 USD
52W Low0.7600 USD
Profitability
Gross Margin67.95%
Oper. Margin-8.22%
EBITDA Margin18.15%
Profit Margin-5.63%
ROE7.51%
ROA-4.87%
Growth
Revenue Growth23.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.09M USD
CapEx (TTM)—
FCF Margin-11.88%
FCF Yield-6.18%
Net Debt387.65M USD
Net Debt/EBITDA5.11
Balance Sheet
Debt/Equity-0.84
Current Ratio1.53
Quick Ratio0.96
Book Value/Sh-1.2310 USD
Cash/Share0.6070 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.0 (Hold)
Target (Mean)3.190 USD
Target Range3.160 USD – 3.280 USD
# Analysts4
Ownership
Shares Out.257.43M
Float255.18M
Insiders0.68%
Institutions69.78%
Short Interest
Short Ratio4.7d
Short % Float14.37%
Short % Out.14.15%
Shares Short36.43M
Short (prev mo.)33.13M
Technical
SMA 502.572 (+21.5%)
SMA 2002.916 (+7.2%)
Beta0.91
S&P 52W Chg28.31%
Avg Vol (30d)16.95M
Avg Vol (10d)10.77M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—